Reuters Market Eye – Cipla falls 2.39 pct after July-Sept incomes. The drugmaker’s Q2 earnings dropped 16 pct to 2.99 billion rupees ($48.6 million) on slow-moving exports. Export sales in the quarter dropped by 4.6 percent, baseding on company presentation. Exports primarily attacked by greater captive intake of resources, even more concentration on combination into brand-new markets – Analysts ($1 = 61.5900 rupees) (Reporting by Abhishek Vishnoi)Investment & & Business InformationFinance